These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18182325)

  • 1. Can estimates of antimalarial efficacy from field studies be improved?
    Gatton ML; Cheng Q
    Trends Parasitol; 2008 Feb; 24(2):68-73. PubMed ID: 18182325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The current status of the resistance of malaria pathogens to antimalarials].
    Kondrashin AV; Baranova AM; Morozov EN; Morozova LF; Stepanova EV
    Med Parazitol (Mosk); 2014; (3):51-7. PubMed ID: 25286554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malaria historians: analyze your old slides!
    Sibley CH
    Trends Parasitol; 2006 Jun; 22(6):243-4. PubMed ID: 16632405
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials.
    Koepfli C; Mueller I; Marfurt J; Goroti M; Sie A; Oa O; Genton B; Beck HP; Felger I
    J Infect Dis; 2009 Apr; 199(7):1074-80. PubMed ID: 19275476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New Guinea.
    Barnadas C; Senn N; Iga J; Timinao L; Javati S; Malau E; Rarau P; Reeder JC; Siba P; Karunajeewa H; Zimmerman PA; Davis TM; Mueller I
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6958-61. PubMed ID: 25155586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control.
    Gama BE; Lacerda MV; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Mem Inst Oswaldo Cruz; 2011 Aug; 106 Suppl 1():159-66. PubMed ID: 21881770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria.
    Happi CT; Gbotosho GO; Sowunmi A; Falade CO; Akinboye DO; Gerena L; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Am J Trop Med Hyg; 2004 Jan; 70(1):20-6. PubMed ID: 14971693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and biological aspects of antimalarial resistance in Plasmodium falciparum and Plasmodium vivax.
    Bustamante C; Batista CN; Zalis M
    Curr Drug Targets; 2009 Mar; 10(3):279-90. PubMed ID: 19275564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic responses of Plasmodium vivax and P. falciparum to chloroquine, in an area of western India where P. vivax predominates.
    Srivastava HC; Yadav RS; Joshi H; Valecha N; Mallick PK; Prajapati SK; Dash AP
    Ann Trop Med Parasitol; 2008 Sep; 102(6):471-80. PubMed ID: 18782486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why is it important to study malaria epidemiology in India?
    Singh V; Mishra N; Awasthi G; Dash AP; Das A
    Trends Parasitol; 2009 Oct; 25(10):452-7. PubMed ID: 19734097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.
    Schunk M; Kumma WP; Miranda IB; Osman ME; Roewer S; Alano A; Löscher T; Bienzle U; Mockenhaupt FP
    Malar J; 2006 Jul; 5():54. PubMed ID: 16817953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand.
    Brockman A; Paul RE; Anderson TJ; Hackford I; Phaiphun L; Looareesuwan S; Nosten F; Day KP
    Am J Trop Med Hyg; 1999 Jan; 60(1):14-21. PubMed ID: 9988316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite analysis of malaria parasites.
    Orjuela-Sánchez P; Brandi MC; Ferreira MU
    Methods Mol Biol; 2013; 1006():247-58. PubMed ID: 23546796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplicity of Plasmodium falciparum infection predicts antimalarial treatment outcome in Ugandan children.
    Kyabayinze DJ; Karamagi C; Kiggundu M; Kamya MR; Wabwire-Mangen F; Kironde F; Talisuna A
    Afr Health Sci; 2008 Dec; 8(4):200-5. PubMed ID: 20589125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasmodium resistance to antimalarials].
    Cailhol J; Consigny PH
    Rev Prat; 2014 Dec; 64(10):1433-4. PubMed ID: 25665330
    [No Abstract]   [Full Text] [Related]  

  • 17. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.
    Cattamanchi A; Kyabayinze D; Hubbard A; Rosenthal PJ; Dorsey G
    Am J Trop Med Hyg; 2003 Feb; 68(2):133-9. PubMed ID: 12641400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can a single "powerless" mitochondrion in the malaria parasite contribute to parasite programmed cell death in the asexual stages?
    Ch'ng JH; Yeo SP; Shyong-Wei Tan K
    Mitochondrion; 2013 May; 13(3):254-6. PubMed ID: 23123916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of a regional observatory of malarial chemoresistance, an emerging public health problem in the Guyanas region].
    Esterre P; Volney B; Meynard JB; Legrand E
    Bull Soc Pathol Exot; 2009 Aug; 102(3):179-84. PubMed ID: 19739416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assessment of antimalarial drug efficacy in vivo.
    White NJ
    Trends Parasitol; 2022 Aug; 38(8):660-672. PubMed ID: 35680541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.